清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The Effects of Home High-Flow Nasal Cannula Oxygen Therapy on Clinical Outcomes in Patients with Severe COPD and Frequent Exacerbations

医学 慢性阻塞性肺病 鼻插管 氧气疗法 医院焦虑抑郁量表 生活质量(医疗保健) 焦虑 萧条(经济学) 前瞻性队列研究 内科学 物理疗法 套管 重症监护医学 外科 护理部 精神科 宏观经济学 经济
作者
Christiaan Theunisse,Netty de Graaf,Annemiek W. E. Braam,Greet C. Vonk,Sara J. Baart,Huibert H. Ponssen,David Cheung
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:14 (3): 868-868 被引量:9
标识
DOI:10.3390/jcm14030868
摘要

Background: Chronic Obstructive Pulmonary Disease (COPD) is a disease with high morbidity and mortality globally. Exacerbations of COPD are major contributors to disease progression and a decline in health-related quality of life (HRQoL). High-flow nasal cannula (HFNC) oxygen therapy is an innovative therapy that provides humidified and heated blended air and oxygen through a nasal cannula. There is some preliminary evidence supporting the effectiveness of HFNC in managing COPD exacerbations, but there are limited data on its effectiveness when used at home for patients with stable, severe COPD. The aim of the present study is to test the hypothesis that home HFNC can decrease the COPD exacerbations rate and hospital admissions and improve HRQoL measures in severe COPD patients with frequent COPD exacerbations. Methods: In a prospective proof-of-concept interventional multicenter study, 40 GOLD stage III and IV COPD patients with a high disease burden (≥2 exacerbations treated with antibiotics and/or corticosteroids) and ≥1 hospital admission in the last year were included. Patients were given instructions on the usage of HFNC by a ventilation practitioner during a group session. The flow rate was 25–30 L/min and FiO2 was 21–35%. Outcome measures included the COPD exacerbations rate, hospital admissions, in-hospital days, Medical Research Council dyspnea (MRC) score, Clinical COPD Questionnaire (CCQ) score, Hospital Anxiety Depression Scale (HADS) scores and capillary pCO2. Repeated analysis of variance (ANOVA) was used to analyze the data. Significant effects identified in the ANOVA were further examined using Student’s t-tests. Results: After 1 year, 27 patients could be evaluated. The COPD exacerbations rate decreased by 1.40 (mean difference ± SD: 1.40 ± 2.09; p = 0.002), hospital admissions decreased by 0.96 admissions per year (0.96 ± 1.37; p = 0.001), and in-hospital days decreased by 7.22 days (7.22 ± 9.26; p = 0.001). Capillary pCO2 decreased by 0.02 kPa (0.02 ± 0.52; p = 0.85). The CCQ score decreased by 0.06 (0.06 ± 0.96; p = 0.76). The MRC dyspnea score decreased by 0.04 (0.04 ± 0.80; p = 0.81). The HADS anxiety score decreased by 0.63 (0.63 ± 3.12; p = 0.31). And finally, the HADS depression score decreased by 0.32 (0.32 ± 3.48; p = 0.64). There was a significant difference between the normocapnic (capillary pCO2 < 6.0 kPa) group and the hypercapnic group in terms of change in the CCQ score (−0.24 ± 0.55 and 0.49 ± 1.32 decrease, respectively, p = 0.05) and the HADS depression score (−0.76 ± 1.86 and 2.20 ± 4.75 decrease, respectively, p = 0.03) after 1 year of HFNC treatment. Conclusions: One-year-long HFNC therapy significantly decreased the COPD exacerbations rate, hospital admissions, and in-hospital days in severe COPD patients with a high disease burden and frequent COPD exacerbations irrespective of them having hypercapnia and with the HRQoL measures only improving in the hypercapnic group. This may imply that severe COPD patients with a high disease burden and frequent COPD exacerbations, irrespective being hypercapnic, are candidates for treatment with home HFNC oxygen therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
落后的山槐完成签到,获得积分10
15秒前
40秒前
LY发布了新的文献求助10
47秒前
活力尔柳完成签到 ,获得积分10
47秒前
lilylwy完成签到 ,获得积分0
47秒前
朝朝的应助被萧雨墨采纳,获得10
48秒前
单纯的天抒完成签到,获得积分10
48秒前
Maestro_S的应助被科研通管家采纳,获得10
1分钟前
1分钟前
LY完成签到,获得积分10
1分钟前
彩色听筠完成签到,获得积分10
1分钟前
文静的丹彤完成签到,获得积分10
1分钟前
勤劳觅山完成签到,获得积分10
2分钟前
专注寒蕾完成签到,获得积分10
3分钟前
分手吧亚索完成签到 ,获得积分10
3分钟前
无极微光的应助被科研通管家采纳,获得20
3分钟前
3分钟前
3分钟前
3分钟前
urah完成签到,获得积分10
3分钟前
万能图书馆的应助被urah采纳,获得10
3分钟前
yuanmeng434完成签到 ,获得积分10
3分钟前
lily完成签到 ,获得积分10
3分钟前
神勇寄风完成签到,获得积分10
3分钟前
李祺完成签到 ,获得积分10
4分钟前
落寞的姿完成签到,获得积分10
4分钟前
火柴盒完成签到,获得积分10
4分钟前
漂亮的乐曲完成签到,获得积分10
4分钟前
Maestro_S的应助被科研通管家采纳,获得10
5分钟前
5分钟前
5分钟前
5分钟前
urah发布了新的文献求助10
5分钟前
愤怒的微笑完成签到,获得积分10
5分钟前
宣灵薇完成签到 ,获得积分0
5分钟前
浮华乱世完成签到 ,获得积分10
5分钟前
风趣的莫英完成签到,获得积分10
5分钟前
沉默怡完成签到,获得积分10
6分钟前
Bonnie完成签到 ,获得积分10
6分钟前
liunahan完成签到 ,获得积分10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577355
关于积分的说明 21852358
捐赠科研通 7788741
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560106
邀请新用户注册赠送积分活动 2482902